Akash Jain, Ph.D., Senior Scientist I, Discovery Pharmaceutics, Cubist Pharmaceuticals, Inc.
Andrea Leone-Bay, Ph.D., Vice President, Pharmaceutical Research & Development, MannKind Corporation
Andrew Rhim, M.D., Instructor of Medicine, Gastroenterology/Medicine, University of Pennsylvania
Anil K. Patri, Ph.D., Deputy Director, Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research
Anjali Agrawal, Ph.D., Senior Principal Scientist, Pharmaceutical R&D, Boehringer Ingelheim Pharmaceuticals, Inc.
Anne Ryan, Ph.D., Executive Director, Drug Safety Research and Development, Pfizer, Inc
Anthony Bahinski, Ph.D., MBA, FAHA, Lead Senior Staff Scientist, Advanced Technology Team, Wyss Institute for Biologically Inspired Engineering, Harvard University Center for Life Sciences
Arthur M. Brown, Ph.D., President & CEO, ChanTest Corporation
Ban-An Khaw, Ph.D., George D. Behrakis Professor of Pharmaceutical Sciences, Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University
Bobby Singh, Ph.D., Chief Technology Officer, Corium International, Inc.
Calum MacRae, M.D., Ph.D., Physician-Scientist, Department of Medicine, Cardiovascular Research Center, Brigham and Women’s Hospital; Associate Professor, Harvard Medical School
Celina D’Cruz, Ph.D., Principal Scientist I, Oncology Innovative Medicines, R&D, AstraZeneca
Chandan Kumar-Sinha, Ph.D., Research Assistant Professor, Pathology, University of Michigan
Charles Glaus, Ph.D., Scientist, Research Imaging Sciences, Amgen
Chas Bountra, Ph.D., Professor of Translational Medicine & Head, Structural Genomics Consortium, University of Oxford
Chitra Telang, Ph.D., Principal Scientist, Pharmaceutical R&D, Boehringer Ingelheim Pharmaceuticals, Inc.
Christopher P. Leamon, Ph.D., Vice President, Research Endocyte, Inc
Danilo Tagle, Ph.D., Associate Director for Special Initiatives, National Center for Advancing Translational Sciences, National Institutes of Health
Darrin Stuart, Senior Research Investigator II, Novartis Institutes for Biomedical Research
David Borsook, M.D., Ph.D., Director, Center for Pain and the Brain, Harvard Medical School
David Cormode, Ph.D., Assistant Professor, Radiology, University of Pennsylvania
David Heimbrook, Ph.D., CEO, SAIC-Frederick National Laboratory for Cancer Research
David Sidransky, MD, Chairman & Co-Founder, Champions Oncology, Inc.
Dennis E. Discher, Ph.D., Robert D. Bent Chaired Professor, Department of Chemical and Biomolecular Engineering, University of Pennsylva
Dorothy Cimino Brown, D.V.M., Chair, Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania
Dr. Andrew L. Kung, M.D., Ph.D., Director, Pediatric Hematology, Oncology and Stem Cell Transplantation, New York-Presbyterian Morgan Stanley Children’s Hospital/Columbia University Medical Center
Dries Braeken, Ph.D., Research & Development Team Leader, Bio-Nano-Electronics, Imec, Belgium
Dylan Daniel, Ph.D., Investigator III, Oncology Pharmacology, Novartis Institutes for Biomedical Research
Edward Bilsky, Ph.D., Professor, Pharmacology & Director, Center of Excellence in the Neurosciences, University of New England
Emanuele Carosati, Ph.D., Researcher, Department of Chemistry, University of Perugia, Italy
Eric Holland, M.D., Ph.D., Director, Brain Tumor Center; Vice Chair, Translational Research, Department of Surgery, Emily Tow Jackson Chair in Oncology, Memorial Sloan Kettering Cancer Center
Erica Jackson, Ph.D., Scientist, Research Group Leader, Genentech
Eugene Storozynsky, M.D., Ph.D., Assistant Professor of Medicine, Program in Heart Failure and Transplantation Division of Cardiology, University of Rochester Medical Center
Gary Gintant, Ph.D., Research Fellow, Department of Integrative Pharmacology, Global Pharmaceutical Research & Development, AbbVie
Gerry Kenna, Ph.D., Independent Consultant; Former Principal Scientist, Hepatic Target Organ Strategy Lead, Safety Assessment, Molecular Toxicology, AstraZeneca
Glen N. Gaulton, Ph.D., Professor, Pathology and Laboratory Medicine; Executive Vice Dean and CSO, Perelman School of Medicine, University of Pennsylvania
Glenn Merlino, Ph.D., Chief, Molecular Genetics Section, Laboratory of Molecular Biology, Division of Basic Science, National Cancer Institute
Gwenn Danet-Desnoyers, Ph.D., Director, Stem Cell and Xenograft Core, Adjunct Associate Professor, Hematology-Oncology, University of Pennsylvania School of Medicine
Henry Smilowitz, Ph.D., Associate Professor, Cell Biology, University of Connecticut Health Center
Hui Gao, Ph.D., Investigator III, Novartis Institutes for Biomedical Research
James Gee, PhD, Professor and Director, Penn Image and Computing Science Laboratory, University of Pennsylvania
Jean-François Mirjolet, Ph.D., Technology Director, Oncodesign
Jeannie Rojas, Ph.D., Director, Janssen R&D
Jeff Hrkach, Ph.D., Senior Vice President, Technology Research & Development, BIND Biosciences
Jeffrey E. Green, M.D., Chief, Transgenic Oncogenesis and Genomics Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute
Jeffrey Vivian, Ph.D., Director, Neuroscience, Maccine Pte Ltd
Joerg Bluemel, Ph.D., Director, Toxicology, Biologics Safety Assessment/Translational Sciences, MedImmune LLC
John Erve, Ph.D., D.A.B.T., Former Principal Scientist, DMPK, Elan Pharmaceuticals, Inc.
John K. Neubert, D.D.S., Ph.D., Associate Professor, University of Florida
Jonathan Heyen, Ph.D., Principal Scientist, Global Safety Pharmacology, Pfizer Global Research & Development
Jonathan Wall Ph.D., Professor of Medicine, Human Immunology and Cancer Program, Director, Amyloid and Preclinical Molecular Imaging Laboratory, University of Tennessee Graduate School of Medicine
José Miguel Vela, Ph.D., Drug Discovery & Preclinical Development, Esteve
Julia Schueler, Ph.D., DVM, Oncotest GmbH
Julien Mamet, Ph.D., Founder & CSO, Adynxx, Inc.
Karim Dabbagh, Ph.D., Executive Director and Head, External R&D and Innovation Research Units, Pfizer Worldwide R&D
Karyn O’Neil, Ph.D., Chief Scientific Officer, Centyrex Venture, Johnson & Johnson
Kenneth Dunn, Ph.D., Associate Professor of Medicine and Biochemistry, Indiana University
Kevin Ford, Ph.D., MRSC, DABT, Safety Assessment, Genentech, Inc.
Kevin Webster, Ph.D., Vice President, Oncology Research, AstraZeneca
Kris Rutten, Ph.D., Laboratory Head, Pain Pharmacology, Grünenthal GmbH
Kung-I Feng, Ph.D., Principal Scientist, Basic Pharmaceutical Sciences, Merck Sharp & Dohme Corp.
M. Raza Zaidi, Ph.D., Assistant Professor of Biochemistry, Fels Institute for Cancer Research & Molecular Biology, Temple University School of Medicine
Margaret S. Lee, Ph.D., Vice President, Research & Translational Medicine, Zalicus, Inc.
Marian Gindy, Ph.D., Director, Pharmaceutical Sciences, Merck Research Laboratories
Martin Carroll, M.D., Associate Professor, Division of Hematology and Oncology, University of Pennsylvania School of Medicine
Matthew Peters, Ph.D., Principal Scientist, Safety Assessment, Astrazeneca
Michael A. Letavic, Scientific Director and Fellow, Neuroscience, Janssen Research and Development, LLC
Michael Aleo, Ph.D., Research Fellow, Investigative Toxicology, Pfizer Global Research & Development
Michael Doyle, Ph.D., Senior Principal Scientist & Group Leader, Protein Science & Structure, Bristol-Myers Squibb Co.
Michael F. Jarvis, Ph.D., Volwiler Senior Research Fellow & Associate Director, Early Discovery, Pain, AbbVie, Inc.
Michael P. Johnson, Ph.D., Research Advisor, Pain/Migraine DHT, Neuroscience Discovery, Eli Lilly & Co.
Moderator: Peter Houghton, Ph.D., Director, Center for Childhood Cancer, Nationwide Children’s Hospital
Munir Hussain, Ph.D., Distinguished Research Fellow, Drug Product Science & Technology, Bristol-Myers Squibb Co.
Nathaniel Katz, M.D., MS, President & CEO, Analgesic Solutions; Tufts University School of Medicine
Neal Goodwin, Ph. D., Senior Fellow & Director, Business Development, in vivo Pharmacology Services, The Jackson Laboratory
Noël Dybdal, D.V.M., Ph.D., DACVP, Director, Principal Scientist, Safety Assessment, Genentech, Inc.
Norman M. Greenberg, Ph.D., Vice President, Research and Development, MedImmune
Oshrat Frenkel, Ph.D., Director, Research & Development, Immune Pharmaceuticals
Paul Karila, Ph.D., Head, Discovery Services, Cellectricon AB
Paul B. Watkins, M.D., Director, Hamner-UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill
Peter King, Ph.D., Senior Scientist, Molecular Imaging (Oncology), Janssen, Pharmaceutical Companies of Johnson and Johnson
Peter Pitts, President and Co-Founder, Center for Medicine in the Public Interest
Philip S. Low, Ph.D., Ralph C. Corley Distinguished Professor, Department of Chemistry, Purdue University
Prem K. Premsrirut, Ph.D., CEO, Mirimus, Inc.
Rakesh Dixit, Ph.D., DABT, Vice President, Research & Development; Global Head, Biologics Safety Assessment, Pathology & LAR, MedImmune
Richard Harris, Ph.D., Assistant Professor, Anesthesiology; Research Assistant Professor, Internal Medicine, University of Michigan
Robert K. Prud’homme, Ph.D., Professor, Department of Chemical & Biological Engineering, Princeton University
S. Stevens Negus, Ph.D., Professor, Department of Pharmacology and Toxicology, Virginia Commonwealth University
Samir Mitragotri, Ph.D., Professor, Department of Chemical Engineering, University of California, Santa Barbara
Sanjeev Thohan, Ph.D., Senior Research Fellow, Preclinical and Translational Sciences, Novartis Institute for Biomedical Research
Scott Edwards, Ph.D., Vice President and General Manager, R&D, SciFluor Life Sciences, LLC
Serguei Kozlov, Ph.D., Principal Scientist, Center for Advanced Pre-Clinical Research, SAIC-Frederick, Inc.
Serguei Liachenko, Ph.D., Director, Bio-Imaging, National Center for Toxicological Research, Food and Drug Administration
Seungpyo Hong, Ph.D., Assistant Professor of Pharmaceutics and Bioengineering, Department of Biopharmaceutical Sciences, University of Illinois College of Pharmacy
Sonke Svenson, Ph.D., Director, Research, Cerulean Pharma, Inc.
Stephen Zicha, Ph.D., Project Director, Sciences, AstraZeneca Neuroscience Research & Development
Tan A. Ince, M.D., Ph.D., Director, Tumor Stem Cell Division, Interdisciplinary Stem Cell Institute and Associate Professor of Pathology, Braman Family Breast Cancer Institute, Miller School of Medicine, University of Miami
Terry A. Van Dyke, Ph.D., Head, Mouse Cancer Genetics Program; Program Director, Cancer Pathways and Mechanisms, National Cancer Institute
Theresa Zhang, Ph.D., Associate Director, Merck Research Laboratories
Thomas Bocan, Ph.D., Senior Director, Preclinical Imaging, Pharmatherapeutics Precision Medicine, Worldwide Research & Development, Pfizer, Inc.
Tony W. Ho, M.D., Vice President, Clinical Innovative Medicine, AstraZeneca
Tycho Heimbach, Ph.D., Associate Director & Senior Investigator II, Biomedical Research, Novartis Pharmaceuticals Corporation
Uma Prabhakar, Ph.D., Consultant, Office of Cancer Nanotechnology Research NCI-NIH
Vania Kenanova, Ph.D., Head, Pre-clinical PET/ SPECT/CT Imaging Laboratory, Global Imaging Group, Novartis Institute for Biomedical Research
Vineet Kumar, Ph.D., Senior Research Scientist II, Department of Pharmaceutics, AbbVie
Vladimir Torchilin, Ph.D., D.Sc., University Distinguished Professor, Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University
Weiguo Dai, Ph.D., Scientific Director, Fellow, Drug Product Development, Johnson & Johnson
Wendy Halpern, D.V.M., Ph.D., DACVP, Senior Scientist/Pathologist, Genentech, Inc.
Werner Scheuer, Research Leader, Pharma Research and Early Development, Discovery Oncology; Roche Diagnostics GmbH
Willem Mulder, Ph.D., Associate Professor of Radiology, Director Nanomedicine Program, Translational and Molecular Imaging Institute, Mount Sinai School of Medicine
Yuching Yang, Ph.D., Research Scientist, The Hamner-UNC Institute for Drug Safety Sciences
Yvonne Will, Ph.D., Associate Research Fellow, Compound Safety Prediction, Pfizer Global Research & Development